An open-label, single-dose, randomized, 4-period, crossover, bioequivalence study of clinical and commercial formulations of bazedoxifene/conjugated estrogens in healthy postmenopausal women

Trial Profile

An open-label, single-dose, randomized, 4-period, crossover, bioequivalence study of clinical and commercial formulations of bazedoxifene/conjugated estrogens in healthy postmenopausal women

Completed
Phase of Trial: Phase I

Latest Information Update: 10 Dec 2007

At a glance

  • Drugs Conjugated estrogens/bazedoxifene (Primary)
  • Indications Menopausal syndrome
  • Focus Pharmacokinetics
  • Sponsors Pfizer
  • Most Recent Events

    • 10 Dec 2007 Status changed from in progress to completed.
    • 15 Nov 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top